Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

• Main Authors: Shiv Kumar Sarin, Ashok Choudhury, George K. Lau, Ming Hua Zheng, Dong Ji, Sherief Abd-Elsalam, Jaeseok Hwang, Xiaolong Qi, Ian Homer Cua, Jeong Ill Suh, Jun Gi Park, Opass Putcharoen, Apichat Kaewdech, Teerha Piratvisuth, Sombat Treeprasertsuk, Sooyoung Park, Salisa Wejnaruemarn, Diana A. Payawal, Oidov Baatarkhuu, Sang Hoon Ahn, Chang Dong Yeo, Uzziel Romar Alonzo, Tserendorj Chinbayar, Imelda M. Loho, Osamu Yokosuka, Wasim Jafri, Soeksiam Tan, Lau Ing Soo, Tawesak Tanwandee, Rino Gani, Lovkesh Anand, Eslam Saber Esmail, Mai Khalaf, Shahinul Alam, Chun Yu Lin, Wan Long Chuang, A. S. Soin, Hitendra K. Garg, Kemal Kalista, Badamnachin Batsukh, Hery Djagat Purnomo, Vijay Pal Dara, Pravin Rathi, Mamun Al Mahtab, Akash Shukla, Manoj K. Sharma, Masao Omata
• Other Authors: The First Affiliated Hospital of Wenzhou Medical University
• Format: Article
• Published: 2020
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/58345
• Institution: Mahidol University

© 2020, Asian Pacific Association for the Study of the Liver. Background and aims: COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon comorbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver inju...